Lantern Pharma (LTRN.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov13

Lantern Pharma Reports Q3 2025 Net Loss of $4.2 Million

15:26

Nov12

Lantern Pharma released FY2025 9 Months Earnings on November 12 Pre-Market (EST), with actual revenue of USD 0 and EPS of USD -1.2078

14:30

Lantern Pharma released FY2025 Q3 earnings on November 12 Pre-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3856 (forecast USD -0.47)

14:30

Nov6

Lantern Pharma to Release FY2025 Q3 Earnings on November 13, Pre-Market EST, Forecast EPS -0.47 USD

00:09

Nov3

Lantern Pharma Displays AI-Based Cancer Drug Development Pipeline

18:15

Oct30

Lantern Pharma Inc. Makes Breakthrough in Oncology Drug Development with AI Platform RADR®

15:43

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -4.177 M, EPS -0.3856

Aug13

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -4.331 M, EPS -0.4015

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -4.537 M, EPS -0.4206

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change